456 related articles for article (PubMed ID: 8998115)
1. Recent advances in the care of the patient with malignant melanoma.
Reintgen D; Balch CM; Kirkwood J; Ross M
Ann Surg; 1997 Jan; 225(1):1-14. PubMed ID: 8998115
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
3. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
Reintgen D; Rapaport D; Tanabe KK; Ross M
J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
[TBL] [Abstract][Full Text] [Related]
4. The adjuvant treatment of malignant melanoma.
Reintgen D; Kirkwood J
J Fla Med Assoc; 1997 Mar; 84(3):147-52. PubMed ID: 9143164
[TBL] [Abstract][Full Text] [Related]
5. Investment in new technology research can save future health care dollars.
Reintgen D; Albertini J; Milliotes G; Marshburn J; Cruse CW; Rapaport D; Berman C; Glass F; Fensske N; Einstein AB; Lyman G
J Fla Med Assoc; 1997 Mar; 84(3):175-81. PubMed ID: 9143169
[TBL] [Abstract][Full Text] [Related]
6. The role of selective lymphadenectomy in the management of patients with malignant melanoma.
Glass LF; Fenske NA; Messina JL; Cruse CW; Rapaport DP; Berman C; Puleo CA; Heller R; Miliotes G; Albertini J
Dermatol Surg; 1995 Nov; 21(11):979-83. PubMed ID: 7582838
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.
Essner R; Conforti A; Kelley MC; Wanek L; Stern S; Glass E; Morton DL
Ann Surg Oncol; 1999; 6(5):442-9. PubMed ID: 10458681
[TBL] [Abstract][Full Text] [Related]
8. Developing indications for the use of sentinel lymph node biopsy and adjuvant high-dose interferon alfa-2b in melanoma.
Dubois RW; Swetter SM; Atkins M; McMasters K; Halbert R; Miller SJ; Shiell R; Kirkwood J
Arch Dermatol; 2001 Sep; 137(9):1217-24. PubMed ID: 11559220
[TBL] [Abstract][Full Text] [Related]
9. Melanoma. A multidisciplinary approach for the general surgeon.
Reeves ME; Coit DG
Surg Clin North Am; 2000 Apr; 80(2):581-601. PubMed ID: 10836008
[TBL] [Abstract][Full Text] [Related]
10. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.
Gershenwald JE; Mansfield PF; Lee JE; Ross MI
Ann Surg Oncol; 2000 Mar; 7(2):160-5. PubMed ID: 10761797
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement.
McMasters KM; Reintgen DS; Ross MI; Gershenwald JE; Edwards MJ; Sober A; Fenske N; Glass F; Balch CM; Coit DG
J Clin Oncol; 2001 Jun; 19(11):2851-5. PubMed ID: 11387357
[TBL] [Abstract][Full Text] [Related]
12. Principles of sentinel lymph node identification: background and clinical implications.
Cochran AJ; Essner R; Rose DM; Glass EC
Langenbecks Arch Surg; 2000 Jul; 385(4):252-60. PubMed ID: 10958508
[TBL] [Abstract][Full Text] [Related]
13. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
14. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
15. Surgical management of patients with intermediate thickness melanoma: current role of elective lymph node dissection.
Cole DJ; Baron PL
Semin Oncol; 1996 Dec; 23(6):719-24. PubMed ID: 8970593
[TBL] [Abstract][Full Text] [Related]
16. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection.
Clary BM; Mann B; Brady MS; Lewis JJ; Coit DG
Ann Surg Oncol; 2001 May; 8(4):328-37. PubMed ID: 11352306
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
Gershenwald JE; Thompson W; Mansfield PF; Lee JE; Colome MI; Tseng CH; Lee JJ; Balch CM; Reintgen DS; Ross MI
J Clin Oncol; 1999 Mar; 17(3):976-83. PubMed ID: 10071292
[TBL] [Abstract][Full Text] [Related]
18. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.
Morton DL; Thompson JF; Essner R; Elashoff R; Stern SL; Nieweg OE; Roses DF; Karakousis CP; Mozzillo N; Reintgen D; Wang HJ; Glass EC; Cochran AJ
Ann Surg; 1999 Oct; 230(4):453-63; discussion 463-5. PubMed ID: 10522715
[TBL] [Abstract][Full Text] [Related]
19. Current management of melanoma: benefits of surgical staging and adjuvant therapy.
McMasters KM; Swetter SM
J Surg Oncol; 2003 Mar; 82(3):209-16. PubMed ID: 12619066
[TBL] [Abstract][Full Text] [Related]
20. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma.
Gershenwald JE; Berman RS; Porter G; Mansfield PF; Lee JE; Ross MI
Ann Surg Oncol; 2000 Apr; 7(3):226-31. PubMed ID: 10791854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
